11 hours ago
In these new phase 3b/4 data from LEVEL UP, findings on switching from dupilumab to upadacitinib in patients with atopic dermatitis are explored.
14 hours ago
MacDougall discusses the Family Heart Foundation’s recent study indicating that very few adults with ASCVD are receiving guideline-directed therapy.
14 hours ago
Reau and Brown discuss recent research in hepatitis B, C, and D, including use of statins, GLP-1s, and more.
15 hours ago
This summary of the 2026 Maui Derm Conference highlights some of the sessions and interviews to look forward to.
17 hours ago
COPDGene data show bronchodilator response more accurately predicts FEV₁ decline and disease progression than polygenic risk scores, including among smokers with preserved spirometry.